Podar, K <br/><br/>
Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies.  [electronic resource] 

 -  Current cancer drug targets  Nov 2011 
 - 1005-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Standard No.: </label>10.2174/156800911798073113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Antibodies, Monoclonal--therapeutic use<br/>Benzenesulfonates--pharmacology<br/>Hematologic Neoplasms--drug therapy<br/>Humans<br/>Indoles--pharmacology<br/>Multiple Myeloma--blood supply<br/>Neovascularization, Pathologic--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Phthalazines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyridines--pharmacology<br/>Pyrroles--pharmacology<br/>Receptors, Vascular Endothelial Growth Factor--metabolism<br/>Signal Transduction<br/>Sorafenib<br/>Sunitinib<br/>Thalidomide--pharmacology<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Wnt Signaling Pathway